GlassScriptPhysician profile
Nirmeen Haniss-Youssef
NPI 1750340246
$8,841.88
in general payments reported to CMS, 2019-2025
17 companies · $1,357 in 2025
The $1,357 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $705 · 2022: $560 · 2023: $3,239 · 2024: $2,981 · 2025: $1,357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,934 · Travel and Lodging: $3,469 · Consulting Fee: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,933.64 |
| Travel and Lodging | $3,468.71 |
| Consulting Fee | $175.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,289.55 | 2021-2025 | Micra, Linq II, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $1,376.71 | 2022-2025 | Aveir, Jot Dx, Gallant |
| Biosense Webster, INC. | $480.94 | 2022-2025 | Carto 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $237.85 | 2021-2022 | |
| Amarin Pharma, INC. | $88.79 | 2021 | |
| Abbvie INC. | $86.07 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $46.28 | 2021 | |
| Impulse Dynamics (USA) INC. | $45.46 | 2023 | Optimizer |
| Takeda Pharmaceuticals U.S.A., INC. | $37.46 | 2021 | |
| Redhill Biopharma INC. | $24.46 | 2021 | |
| Daiichi Sankyo INC. | $23.76 | 2021 | |
| Eisai INC. | $21.38 | 2021 | |
| Amgen INC. | $20.72 | 2021 | |
| Qol Medical, LLC | $20.00 | 2021 | |
| Pfizer INC. | $16.48 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $14.86 | 2024 | Watchman Flx |
| Arbor Pharmaceuticals, INC. | $11.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirmeen Haniss-Youssef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.